Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial

TRISTAN Study Group - Lancet, 2003 - portal.findresearcher.sdu.dk
Background: Inhaled longacting β2 agonists improve lung function and health status in
symptomatic chronic obstructive pulmonary disease (COPD), whereas inhaled …

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

P Calverley, R Pauwels, J Vestbo… - Lancet (London …, 2003 - pubmed.ncbi.nlm.nih.gov
Background Inhaled long-acting beta2 agonists improve lung function and health status in
symptomatic chronic obstructive pulmonary disease (COPD), whereas inhaled …

[引用][C] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial

P Calverley, R Pauwels, J Vestbo, P Jones - The Lancet, 2003 - Elsevier Limited

[引用][C] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

P CALVERLEY - Lancet, 2003 - cir.nii.ac.jp
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary
disease : a randomised controlled trial | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF] ugent.be

[PDF][PDF] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.(vol 361, pg 449, 2003)

P CALVERLEY, R Pauwels, J VESTBO - LANCET, 2003 - biblio.ugent.be
Background Inhaled longacting β2 agonists improve lung function and health status in
symptomatic chronic obstructive pulmonary disease (COPD), whereas inhaled …

[引用][C] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Commentary

P CALVERLEY, R PAUWELS, J VESTBO… - Lancet (British …, 2003 - pascal-francis.inist.fr
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary
disease: a randomised controlled trial. Commentary CNRS Inist Pascal-Francis CNRS …

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

P Calverley, R Pauwels, J Vestbo - The Lancet, 2003 - elibrary.ru
Presents a study about the combined use of inhaled longacting β [sub 2] agonists and
inhaled corticosteroids to improve lung function and health status in symptomatic chronic …

[引用][C] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

P CALVERLEY - Lancet, 2003 - cir.nii.ac.jp
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease
: a randomised controlled trial | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …